Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FS5FM
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $64,153
Award facts
- Contract value 100% obligated
- $64,152.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $64,152.81 to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Cosentyx (secukinumab) 300 mg pens in 2 mL formulations. This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of June 3, 2025. The contract will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order represents a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a major pharmaceutical distributor supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The company's DLA IDC enables the supply of a comprehensive range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. This specific delivery order for Cosentyx, a specialty immunosuppressant used in treating autoimmune conditions, demonstrates AmerisourceBergen's role in fulfilling critical pharmaceutical requirements for the Defense Health Agency and other government healthcare systems through the flexible and expansive Pharmaceutical Prime Vendor Global Program vehicle.
Quick answers
Who was awarded contract SPE2DB25FS5FM?
SPE2DB25FS5FM was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FS5FM worth?
The government has obligated $64,153 on SPE2DB25FS5FM.
Is contract SPE2DB25FS5FM an order under another contract?
Yes. SPE2DB25FS5FM is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS5FM competed?
The extent of competition for SPE2DB25FS5FM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award